Filing Details
- Accession Number:
- 0001127602-13-016737
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-14 16:37:57
- Reporting Period:
- 2013-05-10
- Filing Date:
- 2013-05-14
- Accepted Time:
- 2013-05-14 16:37:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 920148 | Laboratory Corp Of America Holdings | LH | Services-Medical Laboratories (8071) | 133757370 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1454748 | Jr. T. James Boyle | 531 South Spring Street Burlington NC 27215 | Evp, Chief Operating Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2013-05-10 | 10,000 | $58.57 | 48,162 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-05-10 | 3,334 | $47.89 | 51,496 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2013-05-10 | 47,400 | $60.04 | 98,896 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2013-05-10 | 68,908 | $93.82 | 29,988 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-qualified Stock Options | Disposition | 2013-05-10 | 47,400 | $0.00 | 47,400 | $60.04 |
| Common Stock | Non-qualified Stock Options | Disposition | 2013-05-10 | 10,000 | $0.00 | 10,000 | $58.57 |
| Common Stock | Non-qualified Stock Options | Disposition | 2013-05-10 | 3,334 | $0.00 | 3,334 | $47.89 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-02-11 | 2019-02-11 | No | 4 | M | Direct |
| 0 | 2007-02-23 | 2016-02-23 | No | 4 | M | Direct |
| 0 | 2006-03-01 | 2015-03-01 | No | 4 | M | Direct |
Footnotes
- The price of $93.8188 per share represents a weighted average of sales prices ranging from $93.75 to $93.87 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price.
- Employee stock option (right to buy) granted pursuant to the Laboratory Corporation of America Holdings 2008 Stock Incentive Plan.
- The option vests in three equal annual installments beginning on the date reflected in this column.
- Employee stock option (right to buy) granted persuant to the Laboratory Corporation of America Holdings 2000 Stock Incentive Plan.
Billionaire Hedge Funds
